MyFinsight
Home
Blog
About
Cash and cash
equivalents
$45,663,782
(532.72%↑ Y/Y)
Prepaid expenses
$2,456,401
(88.71%↑ Y/Y)
Restricted cash
$101,317
Other current assets
$22,541
(-80.87%↓ Y/Y)
Total current assets
$48,244,041
(458.60%↑ Y/Y)
Intangibles, net
$3,465,904
(-50.46%↓ Y/Y)
Total assets
$51,709,945
(204.01%↑ Y/Y)
Total liabilities and
stockholders equity
$51,709,945
(204.01%↑ Y/Y)
Total stockholders
equity
$49,839,687
(228.36%↑ Y/Y)
Total liabilities
$1,870,258
(2.16%↑ Y/Y)
Accumulated deficit
-$78,153,795
(-37.44%↓ Y/Y)
Additional paid-in capital
$127,980,571
(77.67%↑ Y/Y)
Total current
liabilities
$1,837,917
(5.81%↑ Y/Y)
Total non-current
liabilities
$32,341
(-65.50%↓ Y/Y)
Accumulated other
comprehensive income
$9,570
(69.95%↑ Y/Y)
Common stock, par value
0.0001 per share,...
$3,341
(349.66%↑ Y/Y)
Accounts payable and
accrued liabilities
$1,837,917
(16.21%↑ Y/Y)
Warrant liabilities -
representative warrants
$32,341
Back
Back
Balance Sheet
Pasithea Therapeutics Corp. (KTTAW)
Pasithea Therapeutics Corp. (KTTAW)
source: myfinsight.com